Oncotarget is an informational medical based journal which publishes researched based articles pertaining to Oncology. Oncotarget has been in business for seven consecutive years and Impact Journals is responsible for the informative and well researched articles.
Andrew Gudkov is responsible for many of Oncotarget articles, Gudkov has become a major contributor to the success of Oncotarget. In addition, Mr. Gudkov is affiliated with the Roswell Cancer Institute. Therefore, he has first hand knowledge of Cancer, current treatment as well as research involved when searching for new and improved Cancer treatment. Download output styles at Endnote.com.
Oncotarget is considered to be an open access journal which has become increasing popular among medical professionals as well as the general public. Each article published by the company is based upon factual data which is well researched and verified prior to publication. The web site provides information on potential new treatments for Cancer as well as general information on preventative measures and Physician theories concerning the origin of certain Cancers.
Treatment options for Cancer has greatly improved over the years. Newer and less invasive Cancer drugs are in the works. Newer Cancer drugs are geared toward destroying malignant tumors without destroying healthy immune cells within the body. Therefore, Cancer therapy will be less harmful to the internal organs and overall system.
Oncotarget is published two times per week. In addition, it is considered one of the top rated medical information journals within the nation. Thus attracting new readers each and every week. It appears that non-medical professionals have gained a better understanding of Cancer and potential causes and treatment by simply reading Oncotarget’s articles. Read more about Oncotarget at Business Insider.
Oncotarget publishes articles citing certain cases in which a specific Cancer was identified. The articles also publish statistics concerning rate of recovery and cure. Even deadly Cancers now appear to more responsive to treatment which in turn prolongs life and helps patients better cope with their diagnosis.
Recent articles published on the Oncotarget web site offer new hope within the area with diseases related Endocrinology as well as diseases which affect the blood and healthy immune cells. Blood diseases can be difficult to treat. However, doctors claim that understanding the complexity of tumor development can help greatly when attempting to properly diagnose and treat potentially fatal Cancers.
Oncotarget welcomes new articles from the medical community. It is important that you follow the important guidelines prior to submission. Currently, the web site is welcoming articles related to Immunology, Cell Death as well as the role Genetics plays in the development of Cancer. Please visit www.impactjournals.com.